GB9523566D0 - Pharmaceutical formulation - Google Patents
Pharmaceutical formulationInfo
- Publication number
- GB9523566D0 GB9523566D0 GBGB9523566.9A GB9523566A GB9523566D0 GB 9523566 D0 GB9523566 D0 GB 9523566D0 GB 9523566 A GB9523566 A GB 9523566A GB 9523566 D0 GB9523566 D0 GB 9523566D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical formulation
- formulation
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9523566.9A GB9523566D0 (en) | 1995-11-17 | 1995-11-17 | Pharmaceutical formulation |
| AU75826/96A AU7582696A (en) | 1995-11-17 | 1996-11-15 | Pharmaceutical formulation |
| PCT/GB1996/002824 WO1997018801A1 (en) | 1995-11-17 | 1996-11-15 | Pharmaceutical formulation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9523566.9A GB9523566D0 (en) | 1995-11-17 | 1995-11-17 | Pharmaceutical formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB9523566D0 true GB9523566D0 (en) | 1996-01-17 |
Family
ID=10784062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB9523566.9A Pending GB9523566D0 (en) | 1995-11-17 | 1995-11-17 | Pharmaceutical formulation |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU7582696A (en) |
| GB (1) | GB9523566D0 (en) |
| WO (1) | WO1997018801A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060029653A1 (en) | 1997-01-29 | 2006-02-09 | Cronk Peter J | Therapeutic delivery system |
| DE19807535A1 (en) * | 1998-02-21 | 1999-08-26 | Asta Medica Ag | Drug combination for treating migraine, migraine-type headaches or pain accompanied by nausea, vomiting or delayed gastric emptying |
| AU3582101A (en) | 2000-03-01 | 2001-09-12 | Euro-Celtique S.A. | The treatment of functional gastrointestinal disorders |
| KR100406352B1 (en) * | 2001-03-29 | 2003-11-28 | 삼성전기주식회사 | Antenna and method for manufacture thereof |
| CN1332664C (en) * | 2002-04-26 | 2007-08-22 | 中国人民解放军军事医学科学院毒物药物研究所 | Snuff |
| CA2662018A1 (en) | 2006-08-30 | 2008-03-06 | David William Smith | Method of imparting a mono-axial or multiaxial stiffness to extruded materials and products resulting therefrom |
| EP2813144A1 (en) | 2006-10-09 | 2014-12-17 | Charleston Laboratories, Inc. | Analgesic compositions comprising an antihistamine |
| JP5714910B2 (en) * | 2008-01-09 | 2015-05-07 | チャールストン ラボラトリーズ,インコーポレイテッド | Pharmaceutical composition |
| WO2011006012A1 (en) | 2009-07-08 | 2011-01-13 | Charleston Laboratories Inc. | Pharmaceutical compositions |
| US20150290211A1 (en) * | 2014-04-10 | 2015-10-15 | Locl Pharma, Inc. | Pharmaceutical compositions |
| JP2019507181A (en) | 2016-03-04 | 2019-03-14 | チャールストン ラボラトリーズ,インコーポレイテッド | Pharmaceutical composition |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2096726T3 (en) * | 1991-09-06 | 1997-03-16 | Mcneilab Inc | COMPOSITIONS CONTAINING TRAMADOL AND ANY CODEINE, OXICODONE OR HYDROCODONE, AND THEIR USE. |
-
1995
- 1995-11-17 GB GBGB9523566.9A patent/GB9523566D0/en active Pending
-
1996
- 1996-11-15 WO PCT/GB1996/002824 patent/WO1997018801A1/en not_active Ceased
- 1996-11-15 AU AU75826/96A patent/AU7582696A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997018801A1 (en) | 1997-05-29 |
| AU7582696A (en) | 1997-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9519363D0 (en) | Pharmaceutical formulation | |
| EG23826A (en) | Pharmaceutical formulations | |
| GB9523752D0 (en) | Pharmaceutical formulations | |
| GB9407386D0 (en) | Pharmaceutical formulation | |
| GB9402203D0 (en) | Pharmaceutical formulation | |
| EP0862431A4 (en) | Pharmaceutical formulation | |
| IL112521A0 (en) | Pharmaceutical formulation | |
| ZA965368B (en) | A pharmaceutical formulation | |
| ZA96124B (en) | A pharmaceutical formulation | |
| GB9405856D0 (en) | Pharmaceutical formulation | |
| GB9416599D0 (en) | Pharmaceutical formulation | |
| GB9523566D0 (en) | Pharmaceutical formulation | |
| GB9502695D0 (en) | Pharmaceutical composition | |
| ZA96526B (en) | Novel pharmaceutical formulation | |
| AP9801196A0 (en) | Pharmaceutical preparation | |
| ZA964372B (en) | A pharmaceutical formulation | |
| ZA965367B (en) | A pharmaceutical formulation | |
| ZA96392B (en) | Pharmaceutical formulations | |
| ZA96122B (en) | A pharmaceutical formulation | |
| GB9418550D0 (en) | Drug formulation | |
| ZA967542B (en) | Pharmaceutical combination preparation comprising keto-profen | |
| GB9500978D0 (en) | Pharmaceutical formulations | |
| GB9502786D0 (en) | Pharmaceutical formulation | |
| GB9525386D0 (en) | Pharmaceutical formulation | |
| HUP9602732A2 (en) | Pharmaceutical composition comprising lanperisone |